Impact BioMedical Inc.
IBO
$0.8501
-$0.0799-8.59%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 0.00 |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | 0.00 |
| SG&A Expenses | 1.88M | 1.60M | 1.72M | 1.63M | 1.46M |
| Depreciation & Amortization | 1.12M | 1.12M | 1.12M | 1.12M | 1.12M |
| Other Operating Expenses | 64.00K | 25.00K | 17.00K | 17.00K | 17.00K |
| Total Operating Expenses | 3.66M | 3.61M | 4.00M | 4.03M | 3.92M |
| Operating Income | -3.66M | -3.61M | -4.00M | -4.03M | -3.92M |
| Income Before Tax | 1.10M | -4.32M | -4.56M | -4.41M | -8.39M |
| Income Tax Expenses | -- | -- | -- | -- | -1.88M |
| Earnings from Continuing Operations | 1.10 | -4.32 | -4.56 | -4.41 | -6.51 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 63.00K | 72.00K | 96.00K | 252.00K | 230.00K |
| Net Income | 1.16M | -4.25M | -4.46M | -4.16M | -6.28M |
| EBIT | -3.66M | -3.61M | -4.00M | -4.03M | -3.92M |
| EBITDA | -3.66M | -3.61M | -3.99M | -4.02M | -3.64M |
| EPS Basic | 0.14 | -0.24 | -0.17 | -0.08 | -0.09 |
| Normalized Basic EPS | 0.09 | -0.15 | -0.10 | -0.05 | -0.03 |
| EPS Diluted | -0.18 | -0.26 | -0.19 | -0.10 | -0.10 |
| Normalized Diluted EPS | -0.10 | -0.15 | -0.10 | -0.05 | -0.03 |
| Average Basic Shares Outstanding | 61.01M | 120.00M | 180.50M | 240.99M | 281.98M |
| Average Diluted Shares Outstanding | 121.50M | 120.00M | 180.50M | 240.99M | 281.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
